Severe malabsorption in autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy syndrome successfully treated with immunosuppression.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9245854.
- Also identified by PMC identifier 1717224.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 15 year old boy with autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy syndrome suffered recurrent episodes of severe intractable diarrhoea, steatorrhoea, and hypocalcaemia. The only treatment modality, which controlled the malabsorption syndrome, was immunosuppression with intravenous high dose methylprednisolone and oral methotrexate maintenance therapy.
Medical subject headings
- Autoimmune Diseases
- Immunosuppressive Agents
- Malabsorption Syndromes
- Polyendocrinopathies, Autoimmune